Antibiotic Treatment for Bacterial Epididymo-orchitis
For sexually acquired epididymo-orchitis in men under 35 years, treat with ceftriaxone 1g IM single dose plus doxycycline 100mg twice daily for 14 days; for men over 35 years with enteric pathogens, use ofloxacin 200-400mg twice daily or levofloxacin 500mg daily for 10-14 days. 1
Treatment Algorithm Based on Age and Risk Factors
Sexually Transmitted Pathogens (Age <35 years, sexually active)
The most recent 2024 European guideline 1 and 2020 BASHH guideline 2 both recommend:
- Ceftriaxone 1g IM single dose (increased from previous 500mg to cover gonorrhea strains with reduced susceptibility)
- PLUS Doxycycline 100mg orally twice daily for 14 days
This dual therapy targets both Neisseria gonorrhoeae and Chlamydia trachomatis, the predominant sexually transmitted pathogens in this age group 2. The higher ceftriaxone dose is critical—this change reflects evolving antimicrobial resistance patterns and should not be reduced 1.
Important caveat: Dual azithromycin therapy is no longer recommended unless cefixime (not ceftriaxone) is used 1. This represents a significant shift from older practices.
Enteric Pathogens (Age >35 years, urinary abnormalities, recent instrumentation)
For patients with:
- Positive urine dipstick for leucocytes/nitrites
- Known urinary tract abnormalities
- Recent urological procedures
- Men who practice insertive anal intercourse
- Not sexually active
- Ofloxacin 200-400mg orally twice daily for 10-14 days, OR
- Levofloxacin 500mg orally daily for 10-14 days
These fluoroquinolones provide excellent coverage for E. coli and other Enterobacterales, which are the predominant pathogens in this population 3, 4. A randomized controlled trial demonstrated ciprofloxacin's superiority over beta-lactams in this setting, with treatment failure rates of 20% vs 40% 3.
Mixed Risk Factors (Both STI and Enteric Risks)
When both sexually transmitted and enteric pathogens are possible 1:
- Ceftriaxone 1g IM single dose
- PLUS Ofloxacin or Levofloxacin (doses as above)
This combination ensures coverage across the entire pathogen spectrum.
Duration Considerations
Standard duration is 10-14 days for most bacterial epididymo-orchitis 2, 3. However:
- Sexually transmitted cases: 14 days of doxycycline is standard 2
- Enteric pathogen cases: 10-14 days of fluoroquinolone therapy 3, 1
- Severe cases requiring hospitalization: May need initial IV therapy followed by oral completion 5
The older recommendation of 3 weeks 5 is no longer standard practice based on more recent guidelines.
Special Pathogen Considerations
Mycoplasma genitalium
If tested and identified 2:
- Moxifloxacin 400mg daily for 7-14 days
Brucellosis (Endemic Regions)
If suspected based on occupational exposure, gradual onset, undulatory fever, and minimal local inflammation 6, 7:
- Doxycycline PLUS Rifampicin for 6 weeks
- This combination prevents the high relapse rate (31%) seen with inadequate treatment 7
Common Pitfalls to Avoid
Don't use ceftriaxone 500mg—the dose must be 1g to ensure adequate gonococcal coverage 1
Don't add azithromycin routinely with ceftriaxone—this is outdated practice unless using cefixime instead 1
Don't undertreate duration—completing the full 10-14 day course is essential even if symptoms improve earlier
Don't forget sexual partner treatment in STI cases—partners must be evaluated and treated while maintaining confidentiality 2
Consider brucellosis in endemic regions—standard therapy will fail, requiring 6-week rifampicin/doxycycline combination 6, 7
Severe Cases Requiring Admission
For patients with severe symptoms, systemic toxicity, or inability to tolerate oral therapy 5:
- Initial IV therapy with aminoglycoside plus cephalosporin
- Transition to oral fluoroquinolone once clinically improved
- Adjust based on culture results when available